NASDAQ: CAPS
Capstone Holding Corp Stock

$1.77+0.01 (+0.57%)
Updated Jun 23, 2025
CAPS Price
$1.77
Fair Value Price
N/A
Market Cap
$9.19M
52 Week Low
$1.58
52 Week High
$4.18
P/E
N/A
P/B
0.34x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
N/A
Earnings
N/A
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.94
Operating Cash Flow
N/A
Beta
1.53
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

CAPS Overview

Capstone Therapeutics Corp., a biotechnology company, develops novel peptides and other molecules for helping patients with under-served medical conditions in the United States. It develops Apo E mimetic peptide molecule AEM-28 and its analogs that have completed Phase Ia and Phase Ib/IIa clinical trials for lipoprotein metabolism. The company was formerly known as OrthoLogic Corp. and changed its name to Capstone Therapeutics Corp. in May 2010. Capstone Therapeutics Corp. was founded in 1987 and is headquartered in Tempe, Arizona.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine CAPS's potential to beat the market

Zen Rating Component Grades

N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Biotech

Industry Rating
F
CAPS
Ranked
Unranked of 462

Top Ranked Stocks in Industry

View Top Biotech Stocks

Be the first to know about important CAPS news, forecast changes, insider trades & much more!

Overview

Due Diligence Score

Industry Average (24)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how CAPS scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

CAPS is good value based on its book value relative to its share price (0.34x), compared to the US Biotechnology industry average (4.42x)
P/B vs Industry Valuation
CAPS's short-term assets ($16.71M) exceed its short-term liabilities ($14.66M)
Short-term Liabilities Financials
CAPS's short-term assets ($16.71M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
There are 30 more CAPS due diligence checks available for Premium users.

Valuation

CAPS price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
0.34x
Industry
4.42x
CAPS is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

CAPS's financial health

Profit margin

Revenue
$7.9M
Net Income
-$1.7M
Profit Margin
-30.8%

Assets to liabilities

Assets
$52.2M
Liabilities
$25.2M
Debt to equity
0.94
CAPS's short-term assets ($16.71M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CAPS's short-term assets ($16.71M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CAPS's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$2.3M
Investing
$0.0
Financing
$4.0M

CAPS vs Biotech Stocks

TickerZen RatingMarket Cap1d %P/EP/B
CAPS$9.19M+0.57%N/A0.34x
EVGN$9.21M-5.48%-0.57x-2.53x
CYCN$9.25M-2.37%-2.48x1.05x
DWTXF$9.10M-2.86%-0.25x1.28x
CLDI$9.06M+1.42%-0.17x1.31x

Capstone Holding Stock FAQ

What is Capstone Holding's quote symbol?

(NASDAQ: CAPS) Capstone Holding trades on the NASDAQ under the ticker symbol CAPS. Capstone Holding stock quotes can also be displayed as NASDAQ: CAPS.

If you're new to stock investing, here's how to buy Capstone Holding stock.

What is the 52 week high and low for Capstone Holding (NASDAQ: CAPS)?

(NASDAQ: CAPS) Capstone Holding's 52-week high was $4.18, and its 52-week low was $1.58. It is currently -57.66% from its 52-week high and 12.03% from its 52-week low.

How much is Capstone Holding's stock price per share?

(NASDAQ: CAPS) Capstone Holding stock price per share is $1.77 today (as of Jun 23, 2025).

What is Capstone Holding's Market Cap?

(NASDAQ: CAPS) Capstone Holding's market cap is $9.19M, as of Jun 24, 2025.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Capstone Holding's market cap is calculated by multiplying CAPS's current stock price of $1.77 by CAPS's total outstanding shares of 5,190,251.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.